Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus. - Wikidata - wikimedia - TriplyDB

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

http://www.wikidata.org/entity/Q45081882

about

Dehydroepiandrosterone for systemic lupus erythematosus Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review.Androgens suppress antigen-specific T cell responses and IFN-γ production during intracranial LCMV infection Association of intrarenal B-cell infiltrates with clinical outcome in lupus nephritis: a study of 192 cases.Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity.Lupus in Baltimore: evidence-based 'clinical pearls' from the Hopkins Lupus Cohort.Emerging drug therapies for systemic lupus erythematosus.Systemic lupus erythematosus: current state of diagnosis and treatment.Autoimmune diseases and reproductive aging.Novel evidence-based systemic lupus erythematosus responder index.Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus.Understanding how we age: insights into inflammaging Update on emerging drug therapies for systemic lupus erythematosus.Novel approaches to therapy for systemic lupus erythematosus: update 2005.Management of systemic lupus erythematosus in Chinese patients.Treatment of lupus: impact on quality of life.Measuring outcomes in systemic lupus erythematosus clinical trials.Fertility preservation methods in young women with systemic lupus erythematosus prior to cytotoxic therapy: experiences from the FertiPROTEKT network.A critical review of clinical trials in systemic lupus erythematosus.Immunomodulators in SLE: Clinical evidence and immunologic actions.Evaluating serum prolactin and serum dehydroepiandrosterone sulfate levels in patients with pemphigus.Update on the treatment of systemic lupus erythematosus.Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study.Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate.Response to: 'belimumab and the measurement of fatigue' by Mazzoni.Testosterone and immune-reproductive tradeoffs in healthy women.Effect of medical castration on CD4+ CD25+ T cells, CD8+ T cell IFN-gamma expression, and NK cells: a physiological role for testosterone and/or its metabolites.Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus.Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus.Psychological correlates of adherence to self-care, disease activity and functioning in persons with systemic lupus erythematosus.Systemic lupus erythematosus.Androgen-Induced Immunosuppression.Sex Hormones in Acquired Immunity and Autoimmune Disease

P2860

Q24243533-F8855B5C-6861-4A62-912C-8A344AA515E4 Q33670694-1DE4A642-F6C8-47CA-9333-A67E9ADB2C7A Q34351248-62528967-5E3B-40D4-8765-4BF39ED6B071 Q34464539-EB5564F2-FA72-4F9A-B30D-8692B0FDEAAF Q36076063-B2224E2B-FEC5-4448-9148-77D542F017DB Q36327384-5948C515-07EF-451E-BBD7-17FAE9418C76 Q36373318-D1B7121E-55D1-4B2A-B77F-B807FA5B6A6C Q36634248-8CB9B1FB-FA5B-453A-B566-E56C0FD6B428 Q36792304-60D408C4-80E2-4FF5-B16C-A24C0222121B Q37248985-9FB2E73A-F86D-4250-B200-56741D18178B Q37356378-996D2368-9642-4173-BF23-0ED03F64618A Q37504605-74558A47-FFC7-42D8-B037-4FD9B64F8EA3 Q37581232-0C436ACB-B12B-4DFD-8B9A-29BCB1C004C5 Q37690745-FA470BD8-79CD-4D78-8B5A-B4601B93393C Q37754557-0021FDA0-FA72-469B-B7D6-98A7901C3796 Q37754815-E3224784-0D01-416B-8B58-0F92435E392F Q37883966-82682086-0A17-4D76-8B8C-72BB2C612F64 Q37914899-29A58386-AF90-4B96-90CE-19893FB4FC4C Q37995966-08F95B26-9B76-4BA0-9557-C871434D6582 Q38833868-68F14A6A-34BE-4902-B07D-5854AFFFFFBE Q38883883-6DE3EB82-AD0D-478D-9E3F-6E5C44E69C84 Q39972420-983C43C2-DCE7-471D-97D5-290513ACB22C Q40311555-E58E3EB4-3813-46A9-B259-AEBFC94E4EF8 Q43041708-D2638679-9223-4BA0-AD41-485CC0110163 Q44254629-537501F3-E08A-4446-9FBB-F7E2FEA1C632 Q46254756-6F66D9A3-E350-4375-9B6A-5E893AB004A7 Q46457231-39819A62-3AE5-4BC8-A7D9-955128C0B8B4 Q46849827-9AB1522A-3D13-4A8B-B055-6B5D2623970F Q46864446-614E9755-B70B-4521-9380-693BF59CCB56 Q48023714-7960173F-0FAB-4987-9627-F2DE223877B0 Q49043536-9B8F8819-E884-4DFA-8B29-D6CDDF223C6B Q50848358-142DA199-EF39-4FFE-A191-70A5E795718A Q55357541-302C8747-2D1F-4834-BFFA-AA2A72DEFAFB Q58583865-9D5ED936-A7E3-4BFB-9C87-9198ACFA0E0C

P2860

Effects of prasterone on disease activity and symptoms in women with active systemic lupus erythematosus.

http://www.wikidata.org/entity/Q45081882

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Effects of prasterone on disea ...... systemic lupus erythematosus.

@en

Effects of prasterone on disea ...... systemic lupus erythematosus.

@nl

type

label

Effects of prasterone on disea ...... systemic lupus erythematosus.

@en

Effects of prasterone on disea ...... systemic lupus erythematosus.

@nl

prefLabel

Effects of prasterone on disea ...... systemic lupus erythematosus.

@en

Effects of prasterone on disea ...... systemic lupus erythematosus.

@nl

P1433

Q45081882-1D701698-ACC3-452D-A5B5-F6DAB25E877C

P1476

Q45081882-5CCBEEEA-3A0C-43AC-8227-D8AE06CF28EE

P2093

Q45081882-073E3957-0681-4A32-B15B-C14D4F1BAA25

Q45081882-0A70942D-31D9-4FCD-A3A5-AFFE06FD2B85

Q45081882-0CE844D6-EAC8-408E-AC59-B9E98AAC5B6F

Q45081882-101E60C3-E52F-419D-B125-9CAF1F3DBEA3

Q45081882-23FC2524-C9F6-45C8-8D34-7B6F373AA513

Q45081882-325D953D-A834-4022-A541-7DB5B77B246D

Q45081882-36797E82-0ED6-4A62-B8ED-E16CECBBF835

Q45081882-3775BA8F-0731-42E2-A9D1-0F86A66E23C8

Q45081882-379E49FE-1635-40B2-A943-EEEC0A99CD1F

Q45081882-3939CAC4-EC01-43F5-AA70-2008A67136B6

P304

Q45081882-57400384-8E8A-4CEC-AC93-2526E556055D

P31

Q45081882-E210D7B9-AD4A-40B3-919A-CEBA754F8C62

P356

Q45081882-2B53DB6B-DC01-470D-80DC-CD1F6B511196

P433

Q45081882-7EC7518D-3B23-481E-8474-C847029B851E

P478

Q45081882-F25AD502-6406-401C-ACB8-0E76032E44DF

P50

Q45081882-A5B86A85-0E3D-4D8C-86B1-7AA5D8D33158

P577

Q45081882-E4A96BCA-974A-4BDF-AF49-4391EE534CF5

P698

Q45081882-D84932FF-A62F-41E1-9280-4B6B4D9DC68E

P356

P1433

Arthritis & Rheumatology

P1476

Effects of prasterone on disea ...... systemic lupus erythematosus.

@en

P2093

Allan L Goldman

http://www.w3.org/2001/XMLSchema#string

Arthur F Kavanaugh

http://www.w3.org/2001/XMLSchema#string

Barri J Fessler

http://www.w3.org/2001/XMLSchema#string

Betty J Quarles

http://www.w3.org/2001/XMLSchema#string

David E Yocum

http://www.w3.org/2001/XMLSchema#string

E William St Clair

http://www.w3.org/2001/XMLSchema#string

Ellen M Ginzler

http://www.w3.org/2001/XMLSchema#string

Jacques R Caldwell

http://www.w3.org/2001/XMLSchema#string

Jill P Buyon

http://www.w3.org/2001/XMLSchema#string

Joan T Merrill

http://www.w3.org/2001/XMLSchema#string

P304

2858-2868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.20427

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P50

Michelle A. Petri

P577

2004-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15452837

http://www.w3.org/2001/XMLSchema#string